Roberts Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Roberts Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$384K	Hold	3,040	–	–	0.09%	92
2026 Q1	$424K	Sell	3,040 -1,195	-28%	-$167K	0.11%	88
2025 Q4	$520K	Hold	4,235	–	–	0.14%	78
2025 Q3	$470K	Sell	4,235 -400	-9%	-$45.5K	0.13%	78
2025 Q2	$514K	Sell	4,635 -300	-6%	-$31.9K	0.15%	74
2025 Q1	$553K	Sell	4,935 -900	-15%	-$92.9K	0.17%	75
2024 Q4	$539K	Sell	5,835 -1,200	-17%	-$108K	0.16%	72
2024 Q3	$599K	Buy	7,035 +130	+2%	+$9.92K	0.19%	70
2024 Q2	$468K	Hold	6,905	–	–	0.16%	73
2024 Q1	$468K	Buy	+6,905	New	+$531K	0.17%	76
2023 Q4	–	Sell	-6,905	Closed	-$547K	–	66
2023 Q3	$547K	Hold	6,905	–	–	0.24%	70
2023 Q2	$532K	Hold	6,905	–	–	0.23%	68
2023 Q1	$567K	Sell	6,905 -70	-1%	-$5.8K	0.26%	68
2022 Q4	$596K	Buy	+6,975	New	+$552K	0.29%	68
2022 Q3	–	Sell	-7,190	Closed	-$452K	–	83
2022 Q2	$452K	Hold	7,190	–	–	0.2%	71
2022 Q1	$429K	Sell	7,190 -35	-0.5%	-$2.24K	0.17%	77
2021 Q4	$524K	Buy	+7,225	New	+$498K	0.19%	77

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Roberts Wealth Advisors's GILD Position: Q2 2026 in Review

Roberts Wealth Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,040 shares worth $384K. The position accounts for 0.09% of the portfolio, ranked #92.

Roberts Wealth Advisors first reported a position in GILD in Q4 2021 and has held it in 17 quarters since. The position peaked at $599K in Q3 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Roberts Wealth Advisors held 3,040 shares of Gilead Sciences worth $384K as of Q2 2026.
Roberts Wealth Advisors left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.09% of Roberts Wealth Advisors's portfolio in Q2 2026, its #92 holding.
Roberts Wealth Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 17 quarters since.
Roberts Wealth Advisors's Gilead Sciences position peaked at $599K in Q3 2024.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Roberts Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.